The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
So on the x axis you have LDLC going down right so from 160 140 120 you know 100 80 60 so descending LDLC and on the y- axis you have mortality cardiovascular mortality so not surprisingly all of these point down as LDLC goes lower uh mort cardiovascular mortality goes lower um what's interesting though is you can see that there are different points in the curve at which it starts to matter more and at some point it flattens out. You don't get as much benefit from reduction.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.